Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 108

1.

Viral hepatitis and liver cancer in Korea: an epidemiological perspective.

Yeo Y, Gwack J, Kang S, Koo B, Jung SJ, Dhamala P, Ko KP, Lim YK, Yoo KY.

Asian Pac J Cancer Prev. 2013;14(11):6227-31. Review.

2.

Hepatitis B vaccination in children: the Taiwan experience.

Ni YH, Chen DS.

Pathol Biol (Paris). 2010 Aug;58(4):296-300. doi: 10.1016/j.patbio.2009.11.002. Epub 2010 Jan 29.

PMID:
20116181
3.

Chronic hepatitis B virus infection in Asian countries.

Merican I, Guan R, Amarapuka D, Alexander MJ, Chutaputti A, Chien RN, Hasnian SS, Leung N, Lesmana L, Phiet PH, Sjalfoellah Noer HM, Sollano J, Sun HS, Xu DZ.

J Gastroenterol Hepatol. 2000 Dec;15(12):1356-61. Review.

PMID:
11197043
5.

Hepatitis B virus infection and hepatocellular carcinoma among parous Taiwanese women: nationwide cohort study.

Fwu CW, Chien YC, Kirk GD, Nelson KE, You SL, Kuo HS, Feinleib M, Chen CJ.

J Natl Cancer Inst. 2009 Jul 15;101(14):1019-27. doi: 10.1093/jnci/djp146. Epub 2009 Jun 17.

PMID:
19535774
6.

Long-term follow-up of children with postnatal immunoprophylaxis failure who were infected with hepatitis B virus surface antigen gene mutant.

Hsu HY, Chang MH, Ni YH, Jeng YM, Chiang CL, Chen HL, Wu JF, Chen PJ.

J Infect Dis. 2013 Apr;207(7):1047-57. doi: 10.1093/infdis/jis943. Epub 2013 Jan 8.

PMID:
23300165
7.

Natural history of chronic hepatitis B REVEALed.

Chen CJ, Yang HI.

J Gastroenterol Hepatol. 2011 Apr;26(4):628-38. doi: 10.1111/j.1440-1746.2011.06695.x. Review.

PMID:
21323729
8.

Perspectives and control of hepatitis B virus infection in Taiwan.

Lin CL, Kao JH.

J Formos Med Assoc. 2015 Oct;114(10):901-9. doi: 10.1016/j.jfma.2015.06.003. Epub 2015 Jul 13. Review.

9.

Hepatitis B vaccination and liver cancer mortality reduction in Korean children and adolescents.

Gwack J, Park SK, Lee EH, Park B, Choi Y, Yoo KY.

Asian Pac J Cancer Prev. 2011;12(9):2205-8.

10.

Clinical features of HBsAg-negative but anti-HBc-positive hepatocellular carcinoma in a hepatitis B virus endemic area.

Shim J, Kim BH, Kim NH, Dong SH, Kim HJ, Chang YW, Lee JI, Chang R.

J Gastroenterol Hepatol. 2005 May;20(5):746-51.

PMID:
15853989
11.

Prevalence and clinical significance of hepatitis D virus co-infection in patients with chronic hepatitis B in Korea.

Kim HS, Kim SJ, Park HW, Shin WG, Kim KH, Lee JH, Kim HY, Jang MK.

J Med Virol. 2011 Jul;83(7):1172-7. doi: 10.1002/jmv.22095. Epub 2011 May 3.

PMID:
21541950
12.

Low prevalence of liver disease but regional differences in HBV treatment characteristics mark HIV/HBV co-infection in a South African HIV clinical trial.

Ive P, MacLeod W, Mkumla N, Orrell C, Jentsch U, Wallis CL, Stevens W, Wood R, Sanne I, Bhattacharya D.

PLoS One. 2013 Dec 6;8(12):e74900. doi: 10.1371/journal.pone.0074900. eCollection 2013.

13.

Hepatitis B virus and primary hepatocellular carcinoma: family studies in Korea.

Hann HW, Kim CY, London WT, Whitford P, Blumberg BS.

Int J Cancer. 1982 Jul 15;30(1):47-51.

PMID:
6288579
14.

What can we learn from hepatitis B virus clinical cohorts?

Lin CL, Tseng TC, Kao JH.

Liver Int. 2015 Jan;35 Suppl 1:91-9. doi: 10.1111/liv.12716. Review.

PMID:
25529093
15.

Hepatitis B virus and cancer prevention.

Chang MH.

Recent Results Cancer Res. 2011;188:75-84. doi: 10.1007/978-3-642-10858-7_6.

PMID:
21253790
16.

High levels of hepatitis B surface antigen increase risk of hepatocellular carcinoma in patients with low HBV load.

Tseng TC, Liu CJ, Yang HC, Su TH, Wang CC, Chen CL, Kuo SF, Liu CH, Chen PJ, Chen DS, Kao JH.

Gastroenterology. 2012 May;142(5):1140-1149.e3; quiz e13-4. doi: 10.1053/j.gastro.2012.02.007. Epub 2012 Feb 11.

PMID:
22333950
17.

Prediction models of long-term cirrhosis and hepatocellular carcinoma risk in chronic hepatitis B patients: risk scores integrating host and virus profiles.

Lee MH, Yang HI, Liu J, Batrla-Utermann R, Jen CL, Iloeje UH, Lu SN, You SL, Wang LY, Chen CJ; R.E.V.E.A.L.-HBV Study Group..

Hepatology. 2013 Aug;58(2):546-54. doi: 10.1002/hep.26385.

PMID:
23504622
18.

Current status of liver diseases in Korea: hepatocellular carcinoma.

Song IH, Kim KS.

Korean J Hepatol. 2009 Dec;15 Suppl 6:S50-9. doi: 10.3350/kjhep.2009.15.S6.S50. Review.

19.

Hepatitis B e antigen and the risk of hepatocellular carcinoma.

Yang HI, Lu SN, Liaw YF, You SL, Sun CA, Wang LY, Hsiao CK, Chen PJ, Chen DS, Chen CJ; Taiwan Community-Based Cancer Screening Project Group..

N Engl J Med. 2002 Jul 18;347(3):168-74.

20.

Cancer prevention by vaccination against hepatitis B.

Chang MH.

Recent Results Cancer Res. 2009;181:85-94. Review.

PMID:
19213561

Supplemental Content

Support Center